Aveanna director granted 18,916 restricted stock units

Aveanna Healthcare Holdings, Inc. director Brent D. Layton reported an acquisition of company stock through an equity award.

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. director Brent D. Layton reported an acquisition of company stock through an equity award. On 02/14/2026, he received 18,916 shares of common stock at a price of $0 per share as a grant of stock-settled restricted stock units subject to one-year cliff vesting. Following this award, he directly beneficially owned 54,258 shares of Aveanna common stock.

Insider Trade Summary

Grant/Award: 18,916 shares

Grant/Award 1 txn

Insider LAYTON BRENT D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	18,916	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 54,258 shares (Direct)

Footnotes (1)

1. F1. Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aveanna Healthcare (AVAH) report for Brent D. Layton?

Aveanna Healthcare director Brent D. Layton reported an equity award. On 02/14/2026, he acquired 18,916 shares of common stock via a grant of stock-settled restricted stock units, increasing his directly held beneficial ownership to 54,258 shares.

Was the Aveanna Healthcare (AVAH) Form 4 transaction a purchase or an award?

The Aveanna Healthcare Form 4 shows an award, not a market purchase. The transaction code “A” and footnote describe a grant of stock-settled restricted stock units, giving Brent D. Layton 18,916 shares at a per-share price of $0.

How many Aveanna Healthcare (AVAH) shares does Brent D. Layton own after this Form 4?

After the reported award, Brent D. Layton beneficially owns 54,258 Aveanna Healthcare common shares. This total reflects his direct holdings following the grant of 18,916 stock-settled restricted stock units reported with a 02/14/2026 transaction date.

What are the vesting terms of the Aveanna (AVAH) restricted stock units granted to Brent D. Layton?

The 18,916 restricted stock units granted to Brent D. Layton are stock-settled and subject to one-year cliff vesting. This means the entire award is scheduled to vest at once after one year, rather than gradually over multiple vesting dates.

What role does Brent D. Layton hold at Aveanna Healthcare (AVAH) in this Form 4?

In this filing, Brent D. Layton is identified as a director of Aveanna Healthcare Holdings, Inc. The Form 4 indicates he is not an officer or 10% owner, and the reported transaction reflects director-level equity compensation.

At what price were the Aveanna Healthcare (AVAH) shares granted to Brent D. Layton?

The 18,916 Aveanna Healthcare shares were granted at a price of $0 per share. This pricing reflects that the transaction is a stock-settled restricted stock unit grant, classified as a grant, award, or other acquisition rather than an open-market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LAYTON BRENT D

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/14/2026		A		18,916(1)	A	$0	54,258	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.

	/s/Jonathan Beckler, as attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.